Pipenzolate bromide
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.311 |
Chemical and physical data | |
Formula | C22H28BrNO3 |
Molar mass | 434.374 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1]
Mechanism of action
Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]
References
- ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Muscarinic antagonists
- Quaternary ammonium compounds
- Piperidines
- Tertiary alcohols
- All stub articles
- Gastrointestinal system drug stubs